Health

The breed is prone to a number of health concerns. Common serious health problems include dilated cardiomyopathy (DCM), cervical vertebral instability (CVI), von Willebrand's disease (a bleeding disorder for which genetic testing has been available since 2000), and prostatic disease. Less serious common health concerns include hypothyroidism and hip dysplasia. Canine compulsive disorder is also common. Studies have shown that the Doberman Pinscher suffers from prostatic diseases (such as bacterial prostatiti, prostatic cysts, prostatic adenocarcinoma, and benign hyperplasia), more than any other breed.

Dilated cardiomyopathy is a major cause of death in Dobermanns. This disease affects the breed more than any other. Nearly 40% of DCM diagnoses are for Dobermann Pinschers, followed by German Shepherds at 13%. More recent studies based on European dogs, however, has indicated that DCM affected rates are much higher for this population than their American relatives: around 58% of European Dobermanns will develop DCM within their lifetime. Research has shown that the breed is affected by an attenuated wavy fiber type of DCM that affects many other breeds, as well as an additional fatty infiltration-degenerative type that appears to be specific to Dobermann Pinscher and Boxer breeds. This serious disease is likely to be fatal in most Dobermanns affected.

Roughly a quarter of Dobermann Pinschers who develop cardiomyopathy die suddenly from seemingly unknown causes, and an additional fifty percent die of congestive heart failure. Among female Dobermanns, the sudden death manifestation of the disease is more common, whereas males tend to develop congestive heart failure. In addition to being more prevalent in Dobermanns, this disease is also more serious in the breed. Following a diagnosis, the average non-Dobermann has an expected survival time of 8 months; for Dobermann Pinschers, however, the expected survival time is less than two months. Although the causes for the disease are largely unknown, there is evidence that it is a familial disease inherited as an autosomal dominant trait. Investigation into the genetic causes of canine DCM may lead to therapeutic and breeding practices to limit its impact.

Health

Greyhounds are typically a healthy and long-lived breed, and hereditary illness is rare. Some Greyhounds have been known to develop esophageal achalasia, gastric dilatation volvulus (also known as bloat), and osteosarcoma. Because the Greyhound's lean physique makes it ill-suited to sleeping on hard surfaces, owners of both racing and companion Greyhounds generally provide soft bedding; without bedding, Greyhounds are prone to develop painful skin sores. The average lifespan of a Greyhound is 10 to 14 years.

Due to the Greyhound's unique physiology and anatomy, a veterinarian who understands the issues relevant to the breed is generally needed when the dogs need treatment, particularly when anesthesia is required. Greyhounds cannot metabolize barbiturate-based anesthesia in the same way that other breeds can because their livers have lower amounts of oxidative enzymes. Greyhounds demonstrate unusual blood chemistry, which can be misread by veterinarians not familiar with the breed and can result in an incorrect diagnosis.

Greyhounds are very sensitive to insecticides. Many vets do not recommend the use of flea collars or flea spray on Greyhounds if the product is pyrethrin-based. Products like Advantage, Frontline, Lufenuron, and Amitraz are safe for use on Greyhounds, however, and are very effective in controlling fleas and ticks.

Greyhounds have higher levels of red blood cells than other breeds. Since red blood cells carry oxygen to the muscles, this higher level allows the hound to move larger quantities of oxygen faster from the lungs to the muscles. Conversely, Greyhounds have lower levels of platelets than other breeds.

Delayed haemorrhage following trauma or routine surgery is more common in greyhounds, with one study reporting significant haemorrhage in 26% of greyhounds following routine gonadectomy, compared to 0-2% in other dog breeds. This is often termed greyhound fibrinolytic syndrome or breed-associated hyperfibrinolysis, where in there is a disorder of the fibrinolysis system without derangement of the primary or secondary coagulation systems, and is also not related to platelet count. In this syndrome there is initial adequate hemostasis following trauma or routine surgical procedures, however 36–48 hours later the site undergoes inappropriate hyperfibrinolysis. This results in delayed bleeding which can result in significant morbidity and mortality. Standard pre-operative blood work does not identify those at risk. It is distinct from common bleeding disorders in other breeds such von Willebrand's disease, which is uncommon in greyhounds. Although high quality research data are lacking, it is thought that this condition can be prevented and treated by administering antifibrinolytic medication such as tranexamic acid via the oral or parenteral route. Intensive care and blood product administration may also be required in severe cases.

Greyhounds do not have undercoats and thus are less likely to trigger dog allergies in humans (they are sometimes incorrectly referred to as "hypoallergenic"). The lack of an undercoat, coupled with a general lack of body fat, also makes Greyhounds more susceptible to extreme temperatures (both hot and cold); because of this, they must be housed inside. Some greyhounds are susceptible to corns on their paw pads; a variety of methods are used to treat them.

The key to the speed of a Greyhound can be found in its light but muscular build, large heart, highest percentage of fast twitch muscle of any breed, double suspension gallop, and extreme flexibility of its spine. "Double suspension rotary gallop" describes the fastest running gait of the Greyhound in which all four feet are free from the ground in two phases, contracted and extended, during each full stride.